PKIS v2.0 A clinical tool for identifying important pharmacokinetic drug-drug interactions
| 1. Accepted major perpetrators | 2. Rejected perpetrators | 3. Unclassifiable | 4. Full table |

haloperidol

  • haloperidol has not been evaluated in the literature showing its role of altering the activities of CYP2D6.
  • CYP2D6
    Not evaluated in the literatureartemether/ lumefantrine
    chlorpheniramine
    chlorpromazine
    cocaine
    doxorubicin
    haloperidol
    ibuprofen
    methadone
    metoclopramide
    nilotinib
    ticlopidine

    Footnotes and References

    Disclaimer
    WARNING: While all efforts were put in to maintain the accuracy and currency of the information, it is possible that the knowledge and electronic tools may contain errors and inadequacy. Both Flinder's University and University of New South Wales are not liable to any damages or losses resulted from such circumstances. Clinical discretions are strongly advised at all times.